208 filings
Page 5 of 11
8-K
oike2dbzqpyxcsvfp7b
10 Dec 20
Aytu BioScience and Neos Therapeutics Announce
8:40am
8-K
q3w23 kz6gkopzu
8 Dec 20
Material Modifications to Rights of Security Holders
4:06pm
8-K
auwhxux tgea
2 Dec 20
Other Events
10:26am
8-K
47pkfjc3j55 8k35oyxf
12 Nov 20
Aytu BioScience Announces Fiscal Q1 2021 Net Revenue of $13.5 Million, an Increase of 839% Year-Over-Year
4:05pm
8-K
v6fnumywkex7n
6 Oct 20
Aytu BioScience Announces Fiscal Q4 2020 Net Revenue of $14.9 Million, an Increase of 82% Sequentially, and 766% Year-Over-Year
4:09pm
8-K
bc4os5 hednkjl
2 Jul 20
Entry into a Material Definitive Agreement
5:14pm
8-K
q4dnafd
29 Jun 20
Regulation FD Disclosure
8:01am
8-K
pxjf6za6
12 Jun 20
Other Events
4:26pm
8-K
txyoo
1 Jun 20
Aytu BioScience Announces $15 Million Debt Retirement
5:08pm
8-K
sh5nfx2 81a5tv
14 May 20
Aytu BioScience Reports Third Quarter Fiscal 2020 Financial Results
4:04pm
8-K
rx50 mdy8vr18y
7 May 20
Aytu BioScience to Report Fiscal Q3 FY 2020 Results and Business Update
8:10am
8-K
dwkxrg9v
1 May 20
Aytu BioScience Announces China Export Clearance of Company’s COVID-19 IgG/IgM Rapid Test
8:00am
8-K
ns306gugbyzjfol kesa
24 Apr 20
Aytu BioScience Announces Results from Annual Stockholders Meeting
8:05am
8-K
bz9b7
23 Apr 20
Aytu BioScience Announces Exclusive Distribution Agreement for COVID-19 IgG/IgM Rapid Test with Singapore-Based Biolidics Limited
8:07am
8-K
k3q1of38abnqq 5hofw
20 Apr 20
Aytu BioScience Signs Exclusive Global License with Cedars-Sinai for Potential Coronavirus Treatment
8:05am
8-K
6388nxn
17 Apr 20
Regulation FD Disclosure
8:26am
8-K
0olz3cjjywrliepc wdi
16 Apr 20
Other Events
8:07am
8-K
qlbfg9dyn9w5dru3
15 Apr 20
Aytu BioScience Provides Update on its Licensed COVID-19 IgG/IgM Rapid Test Supply and Ongoing U.S. Distribution
8:05am
8-K
ildrh6bw
7 Apr 20
Regulation FD Disclosure
8:05am
8-K
02rxlu
3 Apr 20
Aytu BioScience Announces First Commercial Shipment of its 2-10 Minute COVID-19 IgG/IgM Point-of-Care Rapid Test
8:05am